Investors

Key press releases

Key upcoming events

Key corporate presentation

Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).

Cellectis ADS (Nasdaq)

Ticker: CLLS

$19.4100

-0.1000 (-0.5126%)

Prev. close
19.5100
Volume
42,918
High
19.8200
Capitalization
830.363M
Last Update: 35 minutes ago

Cellectis (Euronext Growth Paris)

Ticker: ALCLS

€16.3300

-0.3400 (-2.0396%)

Prev. close
16.6700
Volume
52,182
High
16.5500
Capitalization
693.848M
Last Update: 52 minutes ago

Covering research analysts

Barclays - Gena Wang

Citi - Yigal Nochomovitz

Goldman Sachs - Salveen Richter

Guggenheim - Michael Schmidt

Jefferies – Biren Amin

Jones Trading - Soumit Roy

Kempen - Ingrid Gafanhão

Ladenburg – Wangzhi Li

Oddo BHF - Martial Descoutures

Oppenheimer – Hartaj Singh

Portzamparc – Christophe Dombu

RW Baird - Madhu Kumar

Wells Fargo – Jim Birchenough

William Blair – Raju Prasad

Cellectis contact information

Simon Harnest
Investor Relations USA
+1 646 385 9008

Citibank ADR contact information

Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030

Société Générale Securities Services - Ordinary Shares contact information

Call center in English and French

Monday to Friday from 8:30am to 6pm CEST

+33 (0)2 51 85 67 89